FOMX News and Press, Foamix Pharmaceuticals Ltd.

Foamix Pharmaceuticals Ltd (FOMX) Q4 2020 Earnings Conference Call March 4, 2021 08:30 ET Company Participants Michael Wood - Investor Relations Dave Domzalski - President and Chief Executive Officer Matt Wiley - Chief Commercial Officer Andrew Saik - Chief Financial Officer Iain Stuart - Chi...

Foamix Pharmaceuticals (FOMX): Q4 Non-GAAP EPS of -$0.43; GAAP EPS of -$0.55.Revenue of $4.29M (+2964.3% Y/Y)Press Release For further details see: Foamix Pharmaceuticals reports Q4 results

Foamix Pharmaceuticals Ltd (FOMX) Q3 2020 Earnings Conference Call November 5, 2020 08:30 AM ET Company Participants Michael Wood - LifeSci Advisors David Domzalski - Chief Executive Officer Matthew Wiley - Chief Commercial Officer Andrew Saik - Chief Financial Officer Conference Call Partici...

Our analysis concludes Menlo Therapeutics ( MNLO ) is materially undervalued primarily because, at $1.70 per share, MNLO's enterprise valuation is slightly less than $200MM which is less than 80% of its estimated peak annual sales. In early March 2020 (just before most of the country went into...

Menlo Therapeutics' (NASDAQ: MNLO ) wholly owned subsidiary, Foamix Pharmaceuticals (NASDAQ: FOMX ) has entered into a settlement and license agreement to resolve the remaining pending patent litigation involving Finacea Foam. More news on: Menlo Therapeutics Inc., Foamix Pharmaceut...

Merger activity increased last week with four new deals announced and two deals closing. Out of the four deals announced, three were cash deals and one was an all-stock deal. The acquisition of Forty Seven ([[FTSV]]) by Gilead Sciences ([[GILD]]) was the first deal announced last week. FTSV ...

Thinly traded micro cap Menlo Therapeutics ( MNLO +20% ) is one of the few issues in the green today, up on more than triple normal volume, ahead of the expected March 9 close of its previously announced merger with Foamix Pharmaceuticals ( FOMX +3.2% ) after which the latter will be a...

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...

REHOVOT, Israel and BRIDGEWATER, N.J., Feb. 25, 2020 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (Nasdaq: FOMX) (“Foamix” or the “Company”), a specialty pharmaceutical company focused on developing and commercializing proprietary topical therapies to address ...

REHOVOT, Israel and BRIDGEWATER, N.J., Feb. 18, 2020 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (Nasdaq: FOMX) (“Foamix” or the “Company”), a specialty pharmaceutical company focused on developing and commercializing proprietary topical therapies to address ...